Ampio Pharmaceuticals

Ticker AMPE

Exchange NYSE More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Englewood, Colorado

Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of Ampion, their product candidate, to treat prevalent inflammatory conditions for which there are limited treatment options.

Visit website

REPORT RATINGS

4.8 / 5.0 (162)

Ampio Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 162 reviews.

Ampio Pharmaceuticals

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Ampio Pharmaceuticals has reached its limit for free report views.

Ampio Pharmaceuticals does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.